Beta Bionics
Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet. The iLet Bionic Pancreas System was granted breakthrough designation in all configurations (insulin-only, glucagon-only, and bihormonal), including use with Zealand Pharma’s dasiglucagon, a glucagon analogue with a stability profile in a ready-to-use aqueous solution. It also offers a bionic pancreas device for glucose metabolism to the diabetes community.
Domain
betabionics.com
Country
United StatesIndustry
BiotechnologyEmployees
251-500
Last Funding
$60.0M
Founded
2015
Tech Stack (20 technologies)
Frequently Asked Questions
What technologies does Beta Bionics use?+
Beta Bionics uses 20 technologies including Chart.js, Google Tag Manager, WordPress.
What industry is Beta Bionics in?+
Beta Bionics operates in the Biotechnology industry.
Where is Beta Bionics based?+
Beta Bionics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026